CoreWeave's $30B Backlog Changes Everything

CoreWeave (CRWV) reported a significant Q2 FY2025 backlog surge of 86% YoY, reaching $15B YTD, primarily driven by hyperscale client expansions and an OpenAI commitment, securing multi-year revenue streams via structured contracts that differentiate it from usage-based cloud competitors. Despite high capital intensity, with FY2025 CapEx guided at $20-23B against $5.15-5.35B revenue, the company trades at a premium 12.3x forward P/S, 250% above the sector median, with analysts projecting substantial market cap upside by FY2028, making a recent 15% correction potentially attractive.

Analysis

CoreWeave's (CRWV) Q2 FY2025 outlook is characterized by a significant acceleration in contracted revenue, juxtaposed with high capital intensity and a premium valuation. The company's backlog surged 86% year-over-year, doubling year-to-date from $15 billion, underpinned by expansions with hyperscale clients and a key commitment from OpenAI. This growth is secured through long-term structured contracts, providing multi-year revenue visibility and a strategic differentiation from competitors reliant on usage-based spot pricing. However, this expansion is capital-intensive, with FY2025 CapEx guidance of $20–$23 billion significantly outweighing revenue guidance of $5.15–$5.35 billion. The stock trades at a demanding 12.3x forward price-to-sales multiple, nearly 250% above the sector median, which the market appears to be justifying with long-term projections, as FY2028 revenue estimates imply a potential 162% upside to the market cap. The recent 15% correction in the stock price is presented as a potentially more attractive entry point for investors aligned with this long-term growth narrative.

Key Decisions for Investors

• Given the massive 86% YoY backlog growth providing strong revenue visibility, investors with a high-risk tolerance may view the recent 15% stock price correction as a strategic entry point for a long-term position.
• It is crucial to weigh the premium 12.3x forward P/S valuation and immense capital intensity—with CapEx at approximately 4x guided revenue—against the potential for significant future growth, as this requires flawless execution to justify.
• Investors should closely monitor the rate at which the $15B+ backlog converts to recognized revenue and scrutinize future capital expenditure efficiency to validate that the substantial investments are yielding projected returns.